EUVIMEDEUVIMED entdecken
Crossref

The sleep–microbiome–neurodegeneration triad: A new frontier in neuroimmunology

Gerardo Villalobos-Valdez, Karyme M. Alemán-Villa, David A. Armienta-Rojas, Alberto K. De la Herrán-Arita

Microbes & Immunity · 05.06.2026 · 026020009

DOI: 10.36922/mi026020009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbes & Immunity, online erschienen am 05.06.2026. Verfasst von Gerardo Villalobos-Valdez und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathogenesis of neurodegenerative diseases is increasingly recognized as a systemic failure of homeostatic axes rather than a localized central nervous system event. Central to this paradigm is the “sleep–microbiome–neurodegeneration triad,” a bidirectional framework where dietary inputs, gut microbial metabolites, and sleep architecture converge to regulate neuro–immune health. This mini review critically evaluates the evidence linking these domains, focusing on the mechanical and molecular bridges that facilitate their interaction. This mini review synthesizes data from recent (2015–December 2025) longitudinal clinical cohorts, metagenomic sequencing, and polysomnographic studies. We analyze the biochemical transition of dietary substrates, specifically the shift from fiber-derived short-chain fatty acids to ultra-processed food-induced endotoxemia, and relate these findings to neuroimaging evidence on glymphatic clearance efficiency. The evidence identifies a primary mechanistic “switch” in tryptophan metabolism. While fiber-rich diets promote microbial-led synthesis of serotonin and melatonin, the dysbiosis associated with Western diets upregulates the indoleamine 2,3-dioxygenase pathway. This reroutes tryptophan toward the kynurenine pathway, generating neurotoxic metabolites that correlate with sleep fragmentation. We further delineate how the resulting systemic inflammation primes microglial cells via toll-like receptor 4 signaling, concurrently disrupting slow-wave sleep. This disruption is shown to impair the aquaporin-4-dependent glymphatic system, leading to the reduced clearance of proteopathic aggregates, including β-amyloid and α-synuclein. This mini review proposes that the collapse of the sleep–microbiome–immune axis is a fundamental driver of proteinopathy. By characterizing these interactions, we identify modifiable metabolic checkpoints that offer novel targets for therapeutic intervention. Restoring this triad through precision nutrition and microbial modulation represents a vital strategy for stalling neurodegenerative progression.

Zitieren

APA

Villalobos-Valdez, G., Alemán-Villa, K. M., Armienta-Rojas, D. A., & Herrán-Arita, A. K. D. L. (2026). The sleep–microbiome–neurodegeneration triad: A new frontier in neuroimmunology. Microbes & Immunity, 0(0), 026020009. https://doi.org/10.36922/mi026020009

Vancouver

Villalobos-Valdez G, Alemán-Villa KM, Armienta-Rojas DA, Herrán-Arita AKDL. The sleep–microbiome–neurodegeneration triad: A new frontier in neuroimmunology. Microbes & Immunity. 2026;0(0):026020009. doi:10.36922/mi026020009

BibTeX
@article{VillalobosValdez2026,
  author = {Villalobos-Valdez, Gerardo and Alemán-Villa, Karyme M. and Armienta-Rojas, David A. and Herrán-Arita, Alberto K. De la},
  title = {The sleep–microbiome–neurodegeneration triad: A new frontier in neuroimmunology},
  journal = {Microbes & Immunity},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {026020009},
  doi = {10.36922/mi026020009}
}
Kostenlos starten →